Effect of Apatinib on Serum CD4+CD25+ T cells, NK Cells, and T Cells Subgroup in Malignant Tumor

OBJECTIVE: The immune makers including CD4+CD25+ T cells, natural killer cells, and T cells subgroup were retrospectively analyzed to find the relationship between apatinib and the immune system in the patients treated with apatinib. METHOD: Forty-two patients with advanced malignant tumors orally t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hui-Qin, He, Yi-Fu, Chen, Wen-Ju, Yan, Ying, Wu, Shu-Sheng, Hu, Xiao-Xiu, Ke, Li-Hong, Niu, Jia-Yu, Li, Hui-Min, Xu, Hui-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997845/
https://www.ncbi.nlm.nih.gov/pubmed/31888413
http://dx.doi.org/10.1177/1533033819893667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997845/
https://www.ncbi.nlm.nih.gov/pubmed/31888413
http://dx.doi.org/10.1177/1533033819893667

Ejemplares similares